2 Firms Guide Biogen's $877M Gene Therapy Co. Buy
Neuroscience-focused therapy developer Biogen on Monday said it will take over gene therapy firm Nightstar Therapeutics in a deal worth approximately $877 million, with Ropes & Gray LLP and Skadden Arps...To view the full article, register now.
Already a subscriber? Click here to view full article